Related Experiment Videos
Somatostatin and somatostatin receptors in retinal diseases
P M van Hagen1, G S Baarsma, C M Mooy
1Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands. vanhagen@immd.azr.nl
European Journal of Endocrinology
|November 9, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway.
Journal of scleroderma and related disorders·2024
Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature.
European journal of cancer (Oxford, England : 1990)·2023
Long-term data on efficacy and safety of adalimumab in Behçet's disease.
Clinical immunology (Orlando, Fla.)·2023
Adult orbital xanthogranuloma: long-term follow-up of treated cases.
Eye (London, England)·2022
Genetic testing and reporting: What the endocrinologists should know and can expect (Joint position paper of the ENDO-ERN).
European journal of endocrinology·2026
Acromegalic Osteoarthropathy: A New Paradigm of Pathological Musculoskeletal Remodeling.
European journal of endocrinology·2026
Transcriptomic and proteomic signatures predict in vitro response to mitotane in adrenocortical carcinoma.
European journal of endocrinology·2026
Estradiol and other sex hormone dynamics in menstrual migraine: pathway analysis of hormones in a case-control follow-up study.
European journal of endocrinology·2026
Immune signatures associated with human adrenocortical hypertension.
European journal of endocrinology·2026
Adverse health outcomes across the life course in individuals with six rare bone diseases: a 10-year population-based cohort study.
European journal of endocrinology·2026
New and emerging somatostatin therapies for neuroendocrine tumors: "what is in the pipeline".
Expert opinion on pharmacotherapy·2026
Deeper delving Nav1.8 inhibitor Suzetrigine in chronic pain.
Acta pharmacologica Sinica·2026